GelStat Corp. (OTCMKTS:GSAC – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totaling 3,449 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 916,991 shares, the short-interest ratio is presently 0.0 days.
GelStat Price Performance
GelStat stock remained flat at $0.00 during mid-day trading on Friday. GelStat has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms.
Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms.
Further Reading
- Five stocks we like better than GelStat
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
